Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Simponi receives approval in Europe for treatment of polyarticular juvenile idiopathic arthritis

July 5, 2016

Pimco 2664 presents compounds for rheumatoid arthritis

July 5, 2016

Ampio announces results from phase III PIVOT clinical trial

July 1, 2016

IL-22 linked to aberrant bone formation in spondyloarthropathies

June 28, 2016

Cytonics' recombinant A2M variants attenuate cartilage degeneration in osteoarthritis models

June 23, 2016

GO-FURTHER data demonstrate golimumab improves hemoglobin levels and anemia

June 22, 2016

Safety and pharmacokinetics of anti-IL-17 MAb assessed in phase I study

June 20, 2016

Changes in absolute lymphocyte counts following up to 8 years of tofacitinib treatment

June 17, 2016

Long-term efficacy and safety of canakinumab

June 16, 2016

twoXAR completes preclinical studies to evaluate rheumatoid arthritis candidates

June 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...